The two articles about TomoTherapy are different in many ways. One focuses
more on the struggle of making the new technology available, while the other focuses on
the benefits of the technology. Although the number of cancer patients are on the rise,
TomoTherapy will have a significant role in safely treating these patients.
First, the article "TomoTherapy Gets Big Boost" by Jeff Richgels in The Capital
Times informs the readers from a business standpoint. Richgels states the exact amount of
backlog orders that TomoTherapy incurred along with how much time and money it
would take to fulfill the orders. Richgels also gives credit to several of the investors who
contributed to the growth of the company. Essentially, the article presents a problem and
then explains how that problem is corrected.
On the other hand, the article "Treatment Can Target Radiation" from the Star-
Telegram in Fort Worth, Texas puts emphasis on what TomoTherapy specifically does to
help the patient. Jan Jarvis, the author, interviews a doctor who had prevented a man from
getting his arm amputated thanks to the TomoTherapy. Jarvis tells how the system
calculates the pattern, position, and intensity of the radiation delivery once the doctor
determines how much should be provided.
Second, the styles of the articles are considerably different. The Capital Times is
obviously informing of what is to come by interviewing the TomoTherapy CEO for the
facts. The author speaks about the new facility, which will be used to produce the
"Hi-Art" systems (Richgels). Hi-Art being the term that Richgels uses to express the
modern technology. The article gives us a description of the company itself, such
as the increasing number of employees.
Nevertheless, the Star-Telegram article sheds light on how the customers of the
...